Stabilize first, localize accurately, then separate the highest-yield neurologic branches without premature closure.
⏱ 5-7 min read · Topic 33 of 85
Acute neurologic decline is a stabilization-first problem. This page is educational and does not provide patient-specific dosing instructions.
This page is educational. Antimicrobial and corticosteroid stewardship, rescue medication choice, and referral thresholds should be verified with up-to-date clinical references.
Manual-review caution: verify treatment-boundary statements and antimicrobial sequencing against current, local references before clinical use.
| Branch | High-yield discriminator | Most useful discriminator |
|---|---|---|
| Spinal cord lesion | Asymmetric paresis/ataxia, delayed progression | Anatomic pattern and progression tempo |
| Vestibular disease | Head tilt, vestibular posture, nystagmus | Ocular and postural patterning in early stems |
| Neuromuscular syndrome | Fatigue pattern, weakness, generalized deficits | Response pattern over repeated exam time points |
| Inflammatory / infectious CNS disease | Pain, fever, systemic inflammatory context | Context clues and urgency shifts in next-step sequencing |
| Drug or metabolic mimic | Reversible history or medication clues | Safety checks before final differential closure |
Use this page as a differential-priority scaffold, then verify treatment-pathway specifics with updated clinical references.